Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma is a research paper published in European Journal of Cancer (2020). On theSindex it has a DataRank of 3.9. It has been cited 100 times, with 80 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Base Score Contribution
0.692
From this paper's citation signal
Citation Network Contribution
3.2
From 64 citing papers with measurable signal
Ranked by each citer's contribution to N(p) β log1p(Cq) divided by its reference count β out of 80 citers.
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
Merck Sharp and Dohme
FWCI
4.03
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals